The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis
Open accessAbstract
Chronic liver disease is characterized by an exacerbated accumulation of matrix, causing progressive fibrosis, which may lead to cirrhosis. Transforming growth factor beta (TGF‐β), a well‐known profibrotic cytokine, transduces its signal through the ALK5 ser/thr kinase receptor, and increases transcription of different genes including PAI‐1 and collagens. The identification of GW6604 (2‐phenyl‐4‐(3‐pyridin‐2‐yl‐1 H‐pyrazol‐4‐yl)pyridine), an ALK5 inhibitor, allowed us to evaluate the therapeutic potential of inhibiting TGF‐β pathway in different models of liver disease. A cellular assay was used to identify GW6604 as a TGF‐β signaling pathway inhibitor. This ALK5 inhibitor was then tested in a model of liver hepatectomy in TGF‐β‐overexpressing transgenic mice, in an acute model of liver disease and in a chronic model of dimethylnitrosamine (DMN)‐induced liver fibrosis. In vitro, GW6604 inhibited autophosphorylation of ALK5 with an IC 50 of 140 n M and in a cellular assay inhibited TGF‐β‐induced transcription of PAI‐1 (IC 50: 500 n M). In vivo, GW6604 (40 mg kg−1 p.o.) increased liver regeneration in TGF‐β‐overexpressing mice, which had undergone partial hepatectomy. In an acute model of liver disease, GW6604 reduced by 80% the expression of collagen IA1. In a chronic model of DMN‐induced fibrosis where DMN was administered for 6 weeks and GW6604 dosed for the last 3 weeks (80 mg kg−1 p.o., b.i.d.), mortality was prevented and DMN‐induced elevations of mRNA encoding for collagen IA1, IA2, III, TIMP‐1 and TGF‐β were reduced by 50–75%. Inhibition of matrix genes overexpression was accompanied by reduced matrix deposition and reduction in liver function deterioration, as assessed by bilirubin and liver enzyme levels. Our results suggest that inhibition of ALK5 could be an attractive new approach to treatment of liver fibrotic diseases by both preventing matrix deposition and promoting hepatocyte regeneration. British Journal of Pharmacology (2005) 145, 166–177. doi:10.1038/sj.bjp.0706172
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111490200 · Cited by 432
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278
Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis
Liu, R.-M., & Desai, L. P. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.009 · Cited by 702
Hemmann, S., Graf, J., Roderfeld, M., & Roeb, E. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.003 · Cited by 509
Transforming growth factor β as a therapeutic target in systemic sclerosis
Varga, J., & Pasche, B. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.26 · Cited by 295
Metadata
- Authors
- de Gouville, A., Boullay, V., Krysa, G., Pilot, J., Brusq, J., Loriolle, F., Gauthier, J., Papworth, S. A., Laroze, A., Gellibert, F., & Huet, S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 145
- Issue
- 2
- Pages
- 166-177
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2017463647
- Cited by
- 166
- References
- 1
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis. https://app.cochat.ai/papers/10.1038/sj.bjp.0706172
- The paper
- de Gouville, A., Boullay, V., Krysa, G., Pilot, J., Brusq, J., Loriolle, F., Gauthier, J., Papworth, S. A., Laroze, A., Gellibert, F., & Huet, S. (2005). Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706172
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.